Abstract
The aim of this work is to study the different factors that affect the outcome of living donor liver transplantation for patients with hepatocellular carcinoma (HCC). Between April 2003 to November 2014, 62 patients with liver cirrhosis and HCC underwent living donor liver transplantation (LDLT) in the National Liver Institute, Menoufia University, Egypt. The preoperative, operative, and postoperative data were analyzed. After studying the pathology of explanted liver; 44 (71 %) patients were within the Milan criteria, and 18 (29 %) patients were beyond Milan; 13 (21.7 %) of patients beyond the Milan criteria were also beyond the University of California San Francisco criteria (UCSF) criteria. Preoperative ablative therapy for HCC was done in 22 patients (35.5 %), four patients had complete ablation with no residual tumor tissues. Microvascular invasion was present in ten patients (16 %) in histopathological study. Seven (11.3 %) patients had recurrent HCC post transplantation. The 1, 3, 5 years total survival was 88.7, 77.9, 67.2 %, respectively, while the tumor-free survival was 87.3, 82.5, 77.6 %, respectively. Expansion of selection criteria beyond Milan and UCSF had no increased risk effect on recurrence of HCC but had less survival rate than patients within the Milan criteria. Microvascular invasion was an independent risk factor for tumor recurrence.
Similar content being viewed by others
References
Mejia A, Nazario H, Mantry P (2012) Liver transplantation for hepatocellular carcinoma. In: Abd Eldayem H, Allam N (eds) Liver transplantation—basic issues, vol 13, 1st edn. Intech, Croatia, pp 277–302
Abd Eldayem H (2014) Hepatocellular carcinoma. In: Abd Eldayem H (ed) Hepato-pancreato-biliary surgery, bottom lines, 1st edn. Publishing, Germany, 8: p 79–96
Chan C (2013) Liver transplantation for hepatocellular carcinoma. Liver Cancer 2:338–344
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699
Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403
Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 49(3):832–838
Huo T, Hsu C, Huang Y, Su C, Lin H, Lee R et al (2010) Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy. BMC Gastroentrol 10:146
Vibert E, Azoulay D, Hoti E, Lacopinelli S, Samuel D, Salloum C et al (2010) Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 10:129–137
Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S et al (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95:235–240
Baksh S, DeCaprio J, Burakoff S (2000) Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase 4. Oncogene 19:2820–2827
Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A et al (2005) Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 11(5):497–503
Schwartz M, Roayaie S, Llovet J (2005) How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 43(4):584–589
Hollebecque A, Decaens T, Boleslawski E, Mathurin P, Duvoux C, Pruvot FR et al (2009) Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroenterol Clin Biol 33(5):361–369
Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K et al (1999) Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17(1):324–331
Sotiropoulos GC, Lang H, Nadalin S, Neuhäuser M, Molmenti EP, Baba HA et al (2007) Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors. J Am Coll Surg 205(5):661–675
Shimoda M, Ghobrial R, Carmody I, Anselmo D, Farmer D, Yersiz H et al (2004) Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transpl 10(12):1478–1486
Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR (2009) Surgical management of hepatocellular carcinoma: is the jury still out? Surg Oncol 18(4):298–321
Kondili LA, Lala A, Gunson B, Hubscher S, Olliff S, Elias E et al (2007) Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors for HCC recurrence. Eur J Surg Oncol 33:868–873
Kornberg A, Küpper B, Tannapfel A, Katenkamp K, Thrum K, Habrecht O et al (2010) Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 36:275–280
Li J, Yan L, Yang J, Chen Z, Li B, Zeng Y et al (2009) Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol 15(33):4170–4176
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial Support
None.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zakaria, H.M., Sallam, A.N., Ayoub, I.I. et al. Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma. Indian J Surg 79, 299–307 (2017). https://doi.org/10.1007/s12262-016-1474-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-016-1474-1